Trial Profile
TSC1/2 gene detection and Everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Angiomyolipoma
- Focus Therapeutic Use
- 29 Apr 2016 New trial record